Member Exclusive

Cell therapy weekly: FDA to add 50 additional reviewers, expecting 200 INDs a year by 2020

This week: Hematopoietic stem cell transplantation more effective against MS than existing treatments and xeno-free method produces mesenchymal progenitor cells, moving one step closer to clinical-grade bone.

Go to the profile of RegMedNet
Jan 17, 2019

Please sign in or register for FREE

No comments yet.